🇺🇸 FDA
Patent

US 7112341

Pulmonary administration of dry powder formulations for treating infertility

granted A61KA61K38/24A61K9/0073

Quick answer

US patent 7112341 (Pulmonary administration of dry powder formulations for treating infertility) held by Nektar Therapeutics expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
68
CPC classes
A61K, A61K38/24, A61K9/0073, A61K9/145, A61K9/1623